SAMPLE PREPARATION AND BIOANALYSIS VALIDATION FOR NATURAL PRODUCT SAMPLE by AYUMIATI, IDA et al.
 
 
SAMPLE PREPARATION AND BIOANALYSIS VALIDATION FOR NATURAL PRODUCT SAMPLE 
Review Article 
 
IDA AYUMIATI, FEBRINA AMELIA SAPUTRI, MUCHTARIDI MUCHTARIDI 
Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, University of Padjadjaran, Sumedang, Indonesia 
45363 
Email: muchtaridi@unpad.ac.id 
Received: 14 Jul 2020, Revised and Accepted: 02 Jan 2021 
ABSTRACT 
Bioanalysis study and its validation are important for the application in natural drug discovery and preparation for natural medicine products with 
safe drug development approaches. Bioanalysis data for natural products can provide quantitative information on active compounds from natural 
products for pharmacokinetics, pharmacodynamics, bioavailability, bioequivalence, and toxicokinetics. Bioanalysis validation provides useful 
guidance for obtaining accurate data on drug discovery, preclinical and clinical testing of natural drug product development, and to ensure the 
methods used are suitable for application in testing the samples. In general, sample preparation and validation of the bioanalysis method are part of 
the pharmacokinetic characterization of a chemical compound from the discovery to the development stage of natural material products. Therefore, 
this paper aims to discuss how to prepare samples and validate bioanalysis for natural products. 
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INTRODUCTION 
Natural product or natural material product is a preparation or 
product derived from plant material or plant products, including 
leaves, stems, flowers, roots, and seeds. Plants like this are known as 
crude extracts. In general, crude extracts are sold as an extract. 
Usually, the crude extracts are processed first by the extraction 
process. The extraction process that is commonly used for extraction 
is maceration. This maceration method can use water, ethanol, or 
other solvents that can be used to extract some of the chemicals 
substances in the plant. The resulting product will contain chemical 
compound metabolites such as fatty acids, sterols, alkaloids, 
flavonoids, glycosides, saponins, and others. At present, many 
pharmaceutical dosages are formulated with ingredients from 
natural products or commonly called herbal medicines. Herbal 
medicines must also be standardized and tested for safety to obtain 
efficacy and safety [1]. 
Most of the medicines used are derived from natural ingredients. 
Treatment is carried out by the community back to nature due to 
several things and considerations such as the price of modern drugs 
or expensive synthetic chemical drugs and consideration of the side 
effects caused. Many studies have been reported the 
pharmacological effects of various classes of natural substances. 
These natural ingredients include flavonoids, terpenoids, steroids, 
phenylpropanoids, polyketides, and alkaloids. The bioactivity of a 
candidate compound for the discovery of new drugs. In the 
pharmaceutical field, plants are one of the raw materials used for the 
discovery and development of new medicines, both traditional and 
modern medicine. Associated with the use of natural ingredients as 
medicinal materials and use for treatment in the community, it is 
necessary to be assessed and analyzed regarding the efficacy the 
safety of natural medicinal products that can be scientifically 
justified [1]. 
Many natural medicine products currently available in Indonesia are 
produced based on pharmaceutical standardization references [1]. 
The development of natural products refer to those stipulated by the 
health department, must be scientifically justified. The development of 
natural products must go through six stages, namely selection, 
screening of biological substances, pharmacodynamic testing, toxicity 
testing, and development of preparations of drug formulations as well 
as preclinical and clinical testing in humans. Determination of the 
composition of natural ingredients as ingredients for medicinal 
products that conform to standardization by setting tolerance limits 
for variations in compounds needs to be done to ensure the quality 
and efficacy of natural medicine products [2]. Active compounds of 
natural products can be in the form of crude extract or extracts 
derived from one or several plant species. Both crude extracts and 
extracts contain many active compounds with various chemical 
characteristics such as molecular weight, polarity, solubility, volatility, 
and concentration, ranging from pico to micromolar concentrations 
[3]. So, to guarantee the quality and efficacy of natural medicinal 
products, it is necessary to conduct an evaluation analysis of all the 
components of the compounds in the product [4-7]. 
Many researchers are currently focusing their research on 
developing, improving and optimizing analytical methods for testing 
natural products in the biological matrix to ensure quality, efficacy. 
Bioanalysis is a sub-discipline of analytical chemistry used to 
determine drug concentrations or quantitative levels of xenobiotic 
substances (drugs and their metabolites) and biotic substances such 
as macromolecules, proteins, DNA, large drug molecules [8]. The 
biological matrix that is often used in bioanalysis to determine drug 
levels are blood, serum, plasma, urine, saliva, and cerebrospinal fluid 
[9]. The bioanalysis method was developed to improve sensitivity, 
specificity, accuracy, efficiency, throughput testing, data quality, 
handling and processing of analytical data, analytical costs, and 
impacts on the environment. Bioanalysis methods are widely used to 
quantitatively determine drugs and their metabolites in biological 
matrix and bioanalysis can be applied to clinical pharmacological 
studies, pharmacokinetics, and toxicity profiles of drug substances 
(table 1) [7]. 
The bioanalysis method at the stage of drug analysis in the biological 
matrix has several stages, namely the selection and collection of 
biological samples; sample preparation and extraction of analyte 
from the biological matrix; and analyte detection by several 
quantification methods. In most bioanalysis studies, biological 
samples cannot be tested directly but require pretreatment to 
eliminate endogenous proteins, carbohydrates, salts, and lipids. To 
get the drug analyte contained in the biological matrix accurately, it 
must be carried out in the pretreatment stage, namely the extraction 
stage. The extraction stage becomes the critical success stage in 
bioanalysis to get good and accurate results. Extraction is the 
process of separating the material from the mixture using an 
appropriate solvent [1].  
The bioanalysis method used must be validated. Validation of the 
bioanalysis method usually refers to the rules of the Food and Drug 
Administration (FDA) or the European Medicine Agency (EMA). To 
ensure the safety and effectiveness of natural products or herbal 
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medicines, all processes and methods in making medicines must be 
properly controlled or validated, especially the analytical methods 
used to determine the levels of active substances in the 
preparations. Where the validation of the method is must be able to 
determine the levels of the active substance. Quantitative analysis 
methods must be able to meet the requirements of several 
parameters, namely accuracy, precision, range and linearity, the 
limit of detection (LOD), the limit of quantitation (LOQ), and 
specificity. Besides that, there is also a need for a drug analysis 
method that guarantees the accuracy of research results that can be 
trusted in the biological matrix. Selective and sensitive bioanalysis 
methods for quantitative assessment of a drug and its metabolites 
are essential for successful pre-clinical and clinical pharmacological 
testing. The measurement of analyte from the biological matrix must 
be validated. Validation of the bioanalysis method includes all 
procedures which show that the specific method used for 
quantitative measurement of analyte originating in the biological 
matrix. The basic parameters of validation aim to determine quality 
which includes criteria such as selectivity, sensitivity, linearity, 
accuracy, precision, stability, quantification limit (LOQ), recovery 
(recovery), limit of detection (LOD), reproductivity and roughness 
[10-21]. Therefore, this paper aims to discuss various types of 
sample preparation techniques and bioanalysis validation for 
natural products, which include information on various biological 
sample collection and preparation techniques, discussion of 
biological sample preparation techniques, and discussion of the 
application of bioanalysis to various products natural compound. 
Sample preparation method in bioanalysis 
Sample collection 
The first step in bioanalysis is to determine which biological matrix 
will be used. The biological matrix that is most often used in 
bioanalysis to determine drug levels are blood, serum, plasma, urine, 
saliva, and cerebrospinal fluid. Blood sampling is usually done 
intravenously, through arms or capillaries, sampling from the 
fingertips, or using a biological matrix of urine [22]. 
The selection of a biological matrix for sampling is determined by 
the nature of the analyte in the study. To determine drug levels in 
pharmacokinetic studies, the selection of the biological matrix blood 
and urine, is used to determine the elimination profile of compounds 
from the kidney [18]. Data on drug profiles in the blood are also 
needed in bioavailability testing. The use of plasma blood samples is 
important to describe the profile of drugs in the blood in studies of 
bioavailability or pharmacokinetics [12, 23, 24]. 
Venous blood sampling is usually was taken into a tube with 
anticoagulants, such as EDTA or heparin. Meanwhile, to get blood 
serum, it is drawn into a tube without anticoagulants [25]. Blood 
plasma is obtained when all collected blood is centrifuged at 4000-
14,000 rpm for 5-15 min and as much as 30% to 50% of blood volume 
can be collected. Centrifugation for 15 min at 2,000 x g depletes 
platelets in the plasma sample. Plasma is the biggest component of 
blood. Blood plasma is a liquid part of blood [26]. Blood plasma fills 
around 55-60% of the volume of blood in the body. Blood plasma is 
composed of±92% water, and the remaining 8% is carbon dioxide, 
glucose, amino acids (protein), vitamins, fats, and mineral salts. After 
absorption of the drug, the drug is distributed, then undergoes 
metabolism. The bond of the drug with plasma protein or tissue occurs 
during the drug distribution process. This bond is usually reversible, 
meaning that the drug can again be free from bonds with plasma 
proteins. Its reversible ties indicate that its chemical bonds are weak, 
for example, hydrogen bonds, van der walls force. 
The main components of plasma proteins that bind to drugs are 
albumin, globulin, and lipoprotein. Drugs that are bound to plasma 
proteins cannot penetrate biological membranes and are not 
pharmacologically active or produce effects. Of the various doses of 
the drug given, some will be bound to plasma proteins, some in free 
form, depending on how much the drug's affinity for plasma or 
tissue protein. 
Blood was sampled and collected from human subjects or test animals 
using 5 to 7 ml hypodermic syringe punctures (depending on the 
sensitivity of the test and the total number of samples taken for the 
study conducted) [27]. Blood from veins is drawn into tubes that 
contain anticoagulants such as EDTA, heparin, and others. If plasma 
and serum blood samples are used, the blood that has been sampled 
should be immediately centrifuged at 5000-14,000 rpm for 5-10 min 
[10], then transferred to another tube and clean using a pipette. 
Sample preparation 
Sampling and sample preparation are very important stages for the 
analysis of drugs and their metabolites from the biological matrix. 
Sample preparation is carried out to take analyte and clean samples 
before analyzing to improve detection without interference from the 
endogenous content of the biological matrix and does not interfere 
the detection of an analyte by the introduction of biological matrix 
or compounds from natural drugs themselves [9] [table 1]. The 
biological matrix can usually interfere the detection process of 
analyte or drugs. Materials in the biological matrix that can interfere 
the analysis process and block chromatographic columns or 
detectors including proteins, salts, endogenous macromolecules, 
small molecules, and metabolic byproducts. Therefore, the method 
of extracting with suitable solvents and the selection of methods for 
separating drug components from effective biological endogens is 
very important.  
In plasma or serum, the drug is bound to the surface of the protein 
and must be released. The purpose of the analyte extraction process 
from a biological matrix is to first eliminate interference in the 
matrix such as proteins, nucleotides, salts, and others. Secondly to 
concentrate analyte so that they can be detected properly and more 
sensitive, thirdly to improve specificity or selectivity, fourthly to 
improve the analytical performance of the instrument. The choice of 
the method of isolating an analyte compound from the biological 
matrix must be precise because it greatly influences the recovery 
value of the medicinal compounds to be analyzed. 
To support the success of bioanalysis, the sample quality factor is 
very influential on the results of the analysis. Success factors for 
bioanalysis include parameters for collecting biological samples, 
handling and sending samples to the laboratory, sample preparation, 
and storage conditions for the samples during and until the analysis 
process. The separation parameters of the drug from plasma are 
part of the sample preparation stage. Some extraction methods of 
drugs from plasma, (1) Precipitation of proteins (Protein 
Precipitation, PPT) (2) Liquid-liquid extraction (LLE) (3) Solid-
phase extraction (SPE) [table 1].  
Precipitation of proteins (PP) 
Protein precipitation is the simplest separation method for sample 
pretreatment. Protein precipitation is often used for routine analysis 
to remove proteins in a sample or biological matrix. Precipitation 
occurs due to the addition of organic substances, salt accompanied by 
changes in pH that can affect the protein. The principle of precipitation 
of this protein depends on the solubility of the analyte in the specific 
solvent present in the biological matrix [58]. Samples that have been 
mixed with the appropriate solvent are then vortexed and centrifuged. 
The obtained supernatant can be directly injected into the HPLC 
system or evaporated until dry, usually carried out at 40-50 °C under 
nitrogen flow and then dissolved in the appropriate solvent until the 
sample concentration is reached [28]. 
The protein precipitation method has advantages compared to SPE 
as a method for removing interference from the biological matrix. 
The protein precipitation method is more efficient because in time, it 
only requires a short time so the process is faster, the number of 
solvents used is even less. Besides, even then, there are 
disadvantages of this protein precipitation method, which is that 
samples usually still often contain residues from protein and this is a 
non-selective sample cleaning method. There may be a risk of 
endogenous compounds or from medicinal compounds that can 
interfere in the instrument system as well as in HPLC. The protein 
precipitation technique is often combined with the SPE technique to 
produce a cleaner supernatant [25]. 
In this method, there are organic solvents that are commonly used 
as protein precipitators depending on the size of the molecule, the 
size of the protein molecule, and the concentration of the organic 
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solvent used to precipitate the protein. Organic solvents are often 
used to precipitate proteins in plasma. Organic solvents are solvents 
that can be mixed with water such as methanol, ethanol, acetonitrile, 
and acetone [25]. These solvents can reduce the dielectric constant 
of the solution, which causes a decrease in solubility resulting in 
protein deposition. Some studies, methanol, and acetonitrile are 
organic solvents that are often used for the extraction of samples in 
biological fluids. Methanol is used as a protein depositor in plasma 
with the same volume or twice the sample volume. Methanol is also 
the organic solvent most often used among other organic solvents 
because it can produce a clear supernatant which is suitable for 
direct injection into the HPLC system [29]. Ethanol is also used as a 
protein depositor in plasma with the same volume or twice the 
plasma volume. Compared to methanol, ethanol is more effective 
because the longer the chain of alcohol, the easier it is to 
denaturation protein compared to short-chain alcohol. Acetonitrile 
is often used as a protein precipitate. The use of acetonitrile is used 
in the same volume as the plasma volume [1]. Acetonitrile is the best 
solvent that provides the highest depositional presentation with a 
low volume to plasma ratio [30]. 
Liquid-liquid extraction (LLE) 
Liquid-liquid extraction is also included as a simple extraction 
method because this method requires a fairly efficient cost and the 
use of small solvents. This method also has advantages because it 
can extract standard analyte or internal efficiently enough [31]. This 
separation by liquid-liquid extraction is a technique in which a 
solution (usually in water) is made in contact with a second (usually 
organic) solvent, which is essentially incompatible with the first 
solution so that one or more solutes of the first solution move into 
the second solvent [32]. This is based on the selective extraction of 
analytes in liquid samples through mixed organic solvents [9]. This 
separation method is very simple, efficient, fast, and easy to do. 
Separation with this method can be done by shaking the two 
solutions in a separating funnel for several minutes. This technique 
is very suitable for lipophilic compounds. Solvents that are often 
used in liquid-liquid extraction methods include methyl butyl ether 
(MTBE), dichloromethane (DCM), ethyl acetate (EC), diethyl ether 
(DEE), hexane, and others [33-35].  
Solid-phase extraction (SPE) 
Solid-phase extraction (SPE) is a solid-phase extraction method that 
can be used for analysis, separation, purification of samples in 
industrial, pharmaceutical, and toxicological analyzes such as in 
biological liquids (blood, serum, plasma, urine) and food. This 
separation method is where the compound dissolved in the liquid 
mixture is separated from other compounds in the mixture 
according to its physicochemical properties. This solid-phase 
extraction is used to concentrate and purify the sample for analysis. 
SPE is a fairly difficult method for sample preparation, where the 
analyte is bound to the solid phase, the disturbance will disappear 
and the analyte is selectively eluted in the final stage [25]. 
The application of solid-phase extraction is very broad in scope, 
including for sample preparation aimed at the analysis of new drug 
compounds, analysis of metabolites in various biological fluids such 
as blood, serum, and urine, and to separate heavy metal ions from 
other types of metal ions. SPE is a sample separation method that 
uses solid particle material, material for chromatography which is 
usually made in cartridge type packaging which is chemically used 
to separate the various components of a mixed sample. SPE is a 
sample preparation technique used to prepare liquid samples and 
analytic extracts of semi-volatile or non-volatile, but solid samples 
can also be used. The results of quantitative extraction by the SPE 
method are easy, fast, and automatic. The use of solvents and time is 
more effective and efficient [36].  
The principle of Solid Phase Extraction (SPE) is extraction carried 
out by flowing the solution through the solid phase. The analyte 
dissolved in a solvent that has a low elution power is inserted into 
the cartridge and then retained on the SPE medium. The analyte is 
then rinsed with other solvents which have low elution power and is 
finally eluted using solvents with strong volumes of small volumes 
[12, 37]. 
This SPE method is a selective method for sample preparation in 
which the analyte is bound to the solid phase, the dirt is then 
washed and the analyte is selectively eluted. Because of the many 
different sorbent choices, solid-phase extraction is a very powerful 
technique. Solid-phase extraction consists of four main steps, namely 
the conditioning, sample loading or retention, washing, and elution. 
The choice of absorbent in solid-phase extraction is based on its ability 
to bind to the analyte. Where the bond between the analyte and the 
absorber must be stronger than the bond of the analyte with the 
sample matrix so that later the analyte will be held in the absorbent. 
Then the solvent is selected, which can release the bonds between the 
analyte and the absorber at the elution stage [38]. 
 
Table 1: Application of extraction methods in biological samples 









Simultaneous estimation of mangiferin and 
four secoiridoid glycosides in rat plasma 
using liquid chromatography-tandem mass 
spectrometry and its application to the 
pharmacokinetic study of herbal preparation  
Acetonitrile  Plasma LC-MS [1] 
2 Rapid and sensitive liquid 
chromatography-tandem mass 
spectrometric method for the quantitation 
of metformin in human plasma 
Protein 
precipitation 
Acetonitrile  Plasma LC-MS [18] 
3 Determination of metformin in human 
plasma by high-performance liquid 






Plasma HPLC [33] 
4 Ion-pair vortex assisted liquid-liquid 
microextraction with back extraction 
coupled with high-performance liquid 
chromatography-UV for the determination 





The obtained extraction 
recovery was higher 
than the reported results 
using bromothymol blue 
(BTB) which has been 
previously used as an 
ion-pair reagent for the 
LLE of metformin from 
plasma samples 
Plasma HPLC-UV [39] 
5 Determination of metformin in human 




1 butanol: n-hexane 
(1:1) 
Plasma HPLC [33] 
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6 Simple, sensitive, and rapid LC-MS method 
for the quantitation of indapamide in 




Diethyl ether Methanol  Plasma LC–ESI–MS [31] 
7 Simultaneous quantification of antidiabetic 




Acetonitrile: formic acid 
1% 
Plasma UPLC-QToF-MS [40] 
8 Determination of mangiferin in rat plasma 




Acetic Acid: n butanol: 
isopropanol (24: 5: 1) 
 
Plasma UPLC-MS/MS [13] 
9 Pharmacokinetic study of mangiferin in 
human plasma after oral administration 
Liquid-liquid 
extraction 
Acetoacetate: n butanol: 
isopropanol (24: 5: 1) 
Plasma HPLC-MS [14] 
10 Development and validation for the high 
selective quantitative determination of 
metformin in human plasma by cation 
exchanging with normal-phase LC/MS/MS 
SPE (cation 
exchange) 
Methanol, water Plasma LC-MS/MS [38] 
11 Salting-out homogenous extraction 
followed by ionic liquid/ionic liquid-liquid 
micro-extraction for determination of 




Acetonitrile Serum HPLC [41] 
 
12 Development and validation of a multiplex 
UHPLC-MS/MS method for the 
determination of the investigational 
antibiotic against multiresistant 
macozinone tuberculosis (PBTZ169) and 
five active metabolites in human plasma 
Protein 
precipitation 
Methanol Plasma and 
serum 
UHPLC-MS/MS [29] 
13 High-performance liquid chromatographic 
method for the determination of 
mangiferin in rat plasma and urine 
Liquid-liquid 
extraction 






14 Simultaneous determination of 17 Toxic 
alkaloids in human fluids by Liquid 
chromatography coupled with electrospray 
ionization tandem mass spectrometry 
Liquid-liquid 
extraction 
Chloroform: ether  Plasma LC-ESI-MS/MS  [19] 
15 Quantification of fexofenadine in human 
plasma by liquid chromatography coupled 
to electrospray tandem mass spectrometry 





Methanol, water human 
plasma  
LC-MS [43] 
16 Strawberry anthocyanins are recovered in 











MS and HPLC 
with UV-visible 
[12] 
17 Simultaneous quantitation of 3-n-
butylphthalide (NBP) and its four major 
metabolites in human plasma by LC-MS/MS 
using deuterated internal standards 
Protein 
precipitation  
Methanol, chloride acid  plasma LC-MS [44] 
18 Protein 
precipitation  
Comparative pharmacokinetics of baicalin, 
wogonoside, baicalein and wogonin in 
plasma after oral administration of pure 
baicalin, Radix Scutellariae and Scutellariae-
Paeoniae Couple Extracts in Normal and 




Plasma  LC-MS [45] 
19 Identification of Puerarin and its 





Methanol  blood and 
urine 
LC-MS [46] 
20 Sensitive analysis of aconitine, 
hypaconitine, mesaconitine and 
jesaconitine in human body fluids and 
aconitum tubers by LC/ESI-TOF-MS 
Solid-phase 
extraction (SPE) 
Methanol, water, and 
buffer phosphate (pH 
5.5) 





21 Development and validation of a liquid 
Chromatography coupled with atmospheric-
pressure chemical ionization ion trap mass 
spectrometric method for the simultaneous 
determination of Triptolide, Tripdiolide, and 
Tripterine in human serum. 
Liquid-liquid 
extraction 
Ethyl acetate  Serum LC-MS/MS [47] 
22 UPLC-MS/MS method for the simultaneous 
quantification of eight compounds in rat 
plasma and its application to a 
pharmacokinetic study after oral 
administration of veratrum (Veratrum 
nigrum L.) extract 
Protein 
precipitation 
Methanol Plasma UPLC–MS/MS [48] 
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23 Application of a hybrid ion trap/time-of-
flight mass spectrometer in metabolite 
characterization studies: structural 
identification of the metabolism profile of 
antofloxacin in rats rapidly using MSn 
information and accurate mass 
measurements 
Solid-phase 
extraction with a 
C18 cartridge 
(Waters C18 Sep-
Pak, 500 mg) 




24 Separation and identification of Aconitum 






Methanol, water  Urine LC-ESI-MS [49] 
25 Determination of artemether and 
dihydroartemisinin in human plasma with a 
new hydrogen peroxide stabilization method 
Micro-elution 
HLB plate 
Methanol, water Plasma  LC-MS/MS [15] 
26 Determination of capsaicin, nonivamide, 
and dihydrocapsaicin in blood and tissue 






n-butyl chloride LC-MS/MS [50] 
27 Identification and quantification of 
flavonoids in human urine samples by 
column-switching liquid chromatography 
coupled to atmospheric pressure chemical 
ionization mass spectrometry 
Liquid-liquid 
extraction 
10% Methanol, DMSO Urine  HPLC  [51] 
28 Determination of apomorphine in canine 
plasma by liquid chromatography-
electrospray ionization mass spectrometry 
and its application to a pharmacokinetic study 
Liquid-liquid 
extraction 
Diethyl ether  Urine LC-MS [34] 
29 Simultaneous determination of b-
Artemether and its metabolite 
dihydroartemisinin in human plasma and 
urine by a high-performance liquid 
chromatography-mass spectrometry 
an assay using electrospray ionization 
Liquid-liquid 
extraction 
2,2,4 trimethylpentane:  Plasma and 
urine ethyl acetate (7:3 v/v) 
HPLC-MS [52] 
30 Quantitative analysis of artemether and its 
metabolite dihydroartemisinin in human 




 Methyl t-butyl ether Plasma  LC-MS [53] 
31  Rapid Determination of Nicotine in Saliva 
by Liquid Phase Microextraction-High 
Performance Liquid Chromatography 
Microextraction 
(LPME)  
Acetone Saliva  HPLC [54] 
32 Simultaneous determination of nicotine 
and cotinine in serum using high-
performance liquid chromatography with 




Chloroform  Serum  HPLC  [55] 
33 Nicotine and metabolites determination in 
human plasma by ultra-performance liquid 
chromatography-tandem mass spectrometry: 
a simple approach for solving contamination 
problem and clinical application  
Liquid-liquid 
extraction 
Buffer 10 mmol Plasma 
sodium carbonate-
bicarbonate (pH 9.0) 
dan DCM 
LC-MS/MS [56] 
34 Simultaneous determination and 
pharmacokinetic study of gambogic acid 
and gambogenic acid in rat plasma after 
oral administration of Garcinia hanburyi 
extracts by LC-MS/MS 
Liquid-liquid 
extraction 
Ethyl acetate  Plasma  LC-MS/MS [57] 
35 Identification and quantitative 
determination of a major circulating 
metabolite of gambogic acid in human 
Liquid-liquid 
extraction 
Ethyl acetate  Plasma  LC–DAD–
MS/MS 
[58] 
36 HPLC–APCI–MS for the determination of 




Ethanol  Plasma  HPLC–APCI–MS [59] 
37 Determination of gambogic acid in dog 
plasma by high-performance liquid 




Ethyl acetate  Plasma  HPLC  [60] 
 
38  Determination of total and unbound 
sufentanil in human plasma by 
ultrafiltration and LC-MS/MS: application 
to a clinical pharmacokinetic study 
Solid-phase 
extraction (SPE) 
Methanol, water  Plasma  LC-MS/MS [61] 
39 Simultaneous determination of five 
alkaloids by HPLC-MS/MS combined with 
micro-SPE in rat plasma and its application 
to pharmacokinetics after oral 
administration of Lotus Leaf Extract 
Micro SPE  50% methanol in water 
0.1% formic acid in 
water 
Plasma  HPLC-MS/MS [62] 
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40 Determination of armepavine in mouse 
blood by UPLC MS/MS and its application 
to the pharmacokinetic study  
Protein 
precipitation 
Acetonitrile  Blood  UPLC MS/MS [63] 
41 High throughput-SPE based elution coupled 
with UPLC-MS/MS for determination of 
eluxadoline in plasma sample: Application 
in pharmacokinetic characterization of 






Methanol, water, 2% 
formic acid  
Plasma  UPLC-MS/MS [23] 
42 A rapid method to determine colonic 
microbial metabolites derived from grape 





SPE) Oasis HLB 
μ-Elution 
Plates 30 μm 
(Waters, 
Barcelona, Spain) 





43  Application of a rapid μ-SPE clean-up for 
multiclass quantitative analysis of sixteen 
new psychoactive substances in whole 









44 Pharmacokinetics of Nuciferine and N-
Nornuciferine, two major alkaloids from 








45 Plasma and brain pharmacokinetics of 
ganoderic acid A in rats determined by a 
developed UFLC–MS/MS method 
Liquid-liquid 
extraction 
Ethyl acetate  Plasma UFLC–MS/MS 
method 
[67] 
46 A sensitive liquid chromatography-tandem 
mass spectrometry method for 
pharmacokinetics and tissue distribution of 
nuciferine in rats 
Liquid-liquid 
extraction 
Ethyl acetate  Plasma LC-MS/MS [68] 
47 Pharmacokinetic profiles of the five 
isoflavonoids from Pueraria lobata roots in 





Plasma UFLC-MS/MS [20] 
48 HPLC method for the determination and 
pharmacokinetic studies of four 
triterpenoids in rat plasma after oral 






Plasma HPLC [69] 
49 Pharmacokinetics of ganoderic acid D and 





2% hydrochloric acid, 
methanol, acetonitrile  
Plasma  LC-MS/MS [70]  
50  A new quantitation method of protodioscin 
by HPLC-ESI-MS/MS in rat plasma and its 
application to the pharmacokinetic study 
Protein 
precipitation 
Acetonitrile  Plasma  HPLC-ESI-
MS/MS 
[71] 
51 Metabolism and pharmacokinetics in rats 
of ganoderiol F, a highly cytotoxic and 




Methanol, water Plasma  LC/MS/MS [72] 
52 Analysis of anthocyanins in plasma for 
determination of their bioavailability 
Solid-phase 
extraction (SPE) 
0.01M o phosphoric 
acid at a pH of 5.0 set 
with triethyl ammonia 
as eluent. And water/ 
Formic acid/acetonitrile 
(350/50/50) 
Plasma  HPLC  [24] 
53 Simultaneous determination of different 




Aceton, acetic acid  Plasma  HPLC [73] 
54 The identification of flavonoids as 
glycosides in human plasma 
Protein 
precipitation 
Methanol  Plasma  HPLC [74] 
 
55 Determination of steroid hormones in 
human plasma by GC–triple quadrupole MS 
Liquid-liquid 
extraction 






56 A UPLC-MS/MS method for simultaneous 
determination of free and total forms of 
phenolic acid and two flavonoids in rat 
plasma and its application to comparative 
Pharmacokinetic Studies of Polygonum 
capitatum Extract in rats 
Protein 
precipitation 
Methanol  Plasma [16]  UPLC-ESI-
MS/MS 
57 LC-MS/MS determination and 
pharmacokinetic study of seven flavonoids 
in rat plasma after oral administration of 
Cirsium japonicum DC. Extract 
Protein 
precipitation 
Methanol  Plasma  LC-MS/MS [76]  
58 Simultaneous determination of four Protein Methanol  Plasma  LC-MS/MS [17]  
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flavonoids and one phenolic acid in rat 
plasma by LC-MS/MS and its application to 
a pharmacokinetic study after oral 
administration of the Herba Desmodii 
Styracifolii extract 
precipitation 
59 Pharmacokinetic study of four flavones of 
glycyrrhiza in rat plasma using HPLC–MS 
Protein 
precipitation 
Methanol  Plasma  HPLC–MS [77]  
60 Determination of chamaechromone in rat 
plasma by liquid chromatography-tandem 
mass spectrometry:  
Application to a pharmacokinetic study 
Liquid-liquid 
extraction 
Ethyl acetate Plasma  LC-MS/MS [78]  
61 Simultaneous quantification of 
paeoniflorin, nobiletin, tangeretin, 
liquiritigenin, isoliquiritigenin, liquiritin, 
and formononetin from Si-Ni-San extract in 





Oasis HLB SPE 
cartridges 
(30 mg; Milford, 
MA, USA) 
Methanol, water  Plasma LC-MS/MS [79]  
62 Structural pharmacokinetics of 




Ethyl acetate Plasma  UHPLC-MS/MS [80]  
63 Simultaneous determination of seven 
active components in rat plasma by UHPLC-
MS/MS and application to a quantitative 
study after oral administration of Huang-






Plasma  UHPLC–MS/MS [81]  
64 Determination of acacetin in rat plasma by 




Acetonitrile  Plasma  UPLC-MS/MS [35]  
65 Simultaneous determination of vitexin-4”-
O-glucoside, vitexin-2”-O rhamnoside, rutin 
and vitexin from hawthorn leaves 




Methanol  Plasma  UPLC–ESI-
MS/MS 
[82]  
66 UPLC-QTOF-MS Identification of the 
chemical constituents in rat plasma and 
urine after oral administration of Rubia 
cordifolia L. Extract 
Protein 
precipitation 
Methanol  Plasma and 
urine  
UPLC-QTOF-MS [83]  
67 Determination and pharmacokinetic study 




Acetonitrile  Plasma  UPLC-MS/MS [84]  
68  UPLC–MS/MS method for determination of 
avicularin in rat plasma and its application 





Plasma UPLC-MS/MS [21]  
69 Determination of cephalomannine in rat 







Plasma  UPLC-MS/MS [85] 
 
70 Determination of songorine in rat plasma 
by UPLC–MS/MS: Assay development and 
application to the pharmacokinetic study  
Protein 
precipitation 
Acetonitrile  Plasma  UPLC-MS/MS [86]  
71 Determination of parthenolide in rat 
plasma by UPLC-MS/MS and its application 
to a pharmacokinetic study 
Protein 
precipitation 
Acetonitrile  Plasma  UPLC-MS/MS [87] 
 




Ethyl acetate Plasma  UPLC–MS–MS [88] 
 
73 Simultaneous determination of seven 
components from Hawthorn Leaves 
flavonoids in rat plasma by LC-MS/MS 
Protein 
precipitation 
Methanol  Plasma LC-MS/MS [89]  
 
74 Rapid determination of ruscogenin in rat 




Ethyl acetate Plasma  UPLC–MS–MS [90] 
 
75 Quantification of liensinine in rat plasma 
using ultra-performance liquid 
chromatography-tandem mass 
spectrometry and its application to a 
pharmacokinetic study  
Protein 
precipitation 
Acetonitrile  Plasma  UPLC-MS/MS [91]  
76 A Validated HPLC-DAD method for 
simultaneous determination of etodolac 
and pantoprazole in rat plasma 
Protein 
precipitation 
Acetonitrile  Plasma  HPLC-DAD [92] 
 
77 Liquid chromatography/negative ion 
electrospray tandem mass spectrometry 
method for the quantification of 
rosuvastatin in human plasma: Application 
Liquid-liquid 
extraction 
Ethyl ether Plasma  UPLC-MS/MS [93]  
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to a pharmacokinetic study 
78 High-Performance Liquid Chromatographic 
Method for the determination and 
pharmacokinetic study of mangiferin in 
plasma of rats having taken the traditional 
Chinese medicinal preparation Zi-Shen Pil 
Protein 
precipitation 
Acetonitrile  Plasma  HPLC  [94]  
79  Development and validation of an HPLC 
method for simultaneous determination of 




Acetonitrile  Plasma  HPLC  [95]  
80  Determination of mangiferin in rat eyes 
and pharmacokinetic study in plasma after 





acetic acid (9:1, v: v) 
Plasma  HPLC  [96]  
81 Method for analysis of tannic acid and its 
metabolites in biological samples: 




Ethyl Acetate Serum and 
urine  
HPLC  [97]  
82 Evaluation of polyphenol bioavailability 
in rat small intestine 
Protein 
precipitation 
trichloroacetic acid  Tissue Spectrophotome
ter UV-Vis 
[98]  
83 Preparation of Penta-O-galloyl-β-d-glucose 
from tannic acid and plasma 
pharmacokinetic analyses by liquid-liquid 
extraction and reverse-phase HPLC 
Liquid-liquid 
extraction 
Ethyl Acetate Plasma  HPLC [99]  
84 Human pharmacokinetics of ginkgo 
terpene lactones and impact of 
carboxylation in blood on their platelet-
activating factor antagonistic activity 
Liquid-liquid 
extraction 
Ethyl Acetate Plasma  HPLC  [100]  
85 Simultaneous determination of flavonols 
and terpene lactones in beagle dog plasma 
by ultra-performance liquid 
chromatography-tandem-mass 
spectrometry: Application to 




Ethyl Acetate Plasma UPLC-MS [101]  
 
Sample preparation for natural product 
Flavonoids are important secondary metabolites in plants. 
Flavonoids are phenolic compounds, providing pharmacological 
effects such as antioxidants, cytotoxics, antimicrobials, and antivirals 
[51], therapy for diseases such as cardiovascular and 
neurodegenerative [73]. Examples of polyphenol groups include 
catechin, routine, baicalein, quercetin, apigenin-7-glucoside and 
luteolin-7-glucoside are all flavonoids [73]. In 2011 more than 9000 
types of flavonoids were reported used for food supplements. 
Nowadays many supplements or herbal medicines are made by 
utilizing the properties of flavonoid compounds. From one study of 
Swertia chirata (family Gentianaceae) plants. Generally, this plant is 
known by the name "Chirata". This plant is often used for medicines 
because it has pharmacological effects such as antimalarial, a bitter 
stomachic, anthelmintic, and as a remedy for urine scanty, epilepsy, 
ulcer, bronchial asthma, and certain types of mental disorder. Herbal 
medicine based on Polygonum capitatum extract also containing 
phenolic acid and flavonoids is thought to contribute greatly to the 
clinical therapeutic efficacy of P. Capitatum [16].  
Flavonoid compounds in biological fluids are usually extracted using 
ethyl acetate after acidification, whereas alkaloids are usually 
extracted with chloroform or ether after the alkalinization process 
[10, 50]. Saponin and sesquiterpenoids are extracted with n-butanol, 
methylene chloride, ether, or ethyl acetate. The selection of sample 
pretreatment techniques for each analyte in biological fluids 
depends on the expected concentration of the analyte and the 
required detection limits. In the biological type of urine, to obtain 
metabolites with high concentrations, simple sample dilution is 
performed before analysis. With the method of protein precipitation 
using acetonitrile will give good results and removal of proteins for 
quantitative analysis of an analyte in biological fluids. In testing 
analyte in biological liquids, matrix suppression usually occurs; the 
SPE method or liquid-liquid extraction is needed before the 
bioanalysis process is carried out using LC-MS. In other cases, the 
supernatant observed after extraction of protein deposition can be 
combined with continuing SPE procedures or with liquid-liquid 
extraction techniques.  
At the beginning of the study, it was found that the content in chirata 
plants contained compounds of flavonoids, xanthones, terpenoids, 
iridoid, and secoiridoid glycosides. One product from this plant 
extract (Chirata) has been developed as an antidiabetic agent by the 
Central Drug Research Institute (CDRI), Lucknow, from aerial part of 
S. chirata. To find out and realize the pharmacological effects of 
these chirata-based extracts, pharmacokinetic testing of bioactive 
compounds is needed. Mangiferin and amarogentin are two 
bioactive markers of the chirata plant used for standardization. 
Determination of these bioactive compounds from flavonoids by the 
development of LC-MS-based testing. LC-MS/MS detect and measure 
chirata (xanthone glycosides and sekoiridoid) in plasma in a 
sensitive manner, for use in herbal pharmacokinetic testing with 
compounds from chirata in mouse plasma. Analysis with relatively 
low concentrations is usually found in analyzes based on the 
biological sample matrix. The UPLC-ESI-MS/MS system is used to 
measure levels of a compound in plasma or biological matrix. HPLC 
is widely used to separate and analyze flavonoids [73]. The 
analytical method for determining gallic acid, quercitrin, and 
quercetin compounds which are phenolic acids and flavonoids in 
biological samples, is high-performance liquid chromatography 
(HPLC) with MS [16]. The addition of acid to the mobile phase in the 
LC system causes satisfactory peak symmetry and good resolution 
and can significantly increase sensitivity and reduce analysis time 
with columns along with the 50 mm. It was also reported that the 
LC-MS/MS method was quite sensitive and selectively used to 
evaluate the pharmacokinetics of various flavonoid compounds in 
plasma [89]. 
The preparation used for pharmacokinetic testing of flavonoid 
bioactive compounds is by precipitation protein method. The 
precipitation protein method process can be used organic solvents 
such as acetonitrile, acetone, methanol, and ethanol. The extracting 
solvent used for flavonoid compounds is acetonitrile. These organic 
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solvents are widely used as extracting solutions because they 
correspond to the solvents used in the analysis of high-performance 
liquid chromatography or LC-MS/MS. The selection of suitable 
internal standards is also a key factor in the analysis of biological 
samples [16, 17]. Internal standards are used to reduce unknown 
errors that can occur during quantitative testing [17]. 
One of the main groups of flavonoids that have antidiabetic effects is 
mangiferin. Mangiferin, 1,3,6,7-tetrahydroxyxanthone-C-2-d-
glucoside is a natural glucosyl xanthone from the Chinese medicinal 
herb Mangifera indica [13]. Many researchers report that the 
pharmacological effects of mangiferin are antibacterial, antidiabetic, 
and anticancer. Mangiferin is also reported as an oral treatment for 
antidiabetic. To evaluate this mangiferin-based herbal drug, 
pharmacokinetic and bioavailability testing is performed to 
determine absorption in the body and to determine its effectiveness. 
So before testing, proper biological sample preparation is required. 
Measurement of mangiferin in biological samples is very important 
for drug development and a fast and reliable bioanalytic method is 
needed. Blood samples taken from test animals or volunteers are 
immediately centrifuged for separation to avoid damage or 
hydrolysis samples. Blood samples are centrifuged, then plasma or 
serum are transferred to another clean plastic container. Plasma and 
serum that have been separated are stored at-20 °C until used for 
the next analysis stage. After that in extracting mangiferin in 
biological samples, the protein precipitation method is used and the 
solvent used is acetonitrile [94, 96].  
Unlike the case with the method of extracting mangiferin samples 
from biological samples is done by the liquid-liquid extraction 
method. This extraction solution uses 2 ml acetate: n-butanol: 
isopropanol (24: 5: 1, v/v/v). Another procedure also used the way 
the sample was prepared according to the method described by Han 
et al. [13], with slight modifications. 100 µl of plasma was extracted 
using 2 ml of acetoacetate: n-butanol: isopropanol (24: 5: 1, v/v/v) 
after adding 50 μl of hydrochloric acid solution (1 mol/l-1
Research conducted by Dongxiao sun et al., for the simultaneous 
determination of four flavonoids and one phenolic acid in rat plasma 
by the LC-MS/MS method and its application for pharmacokinetic 
studies after oral administration of Desmodii Styracifolii herbal 
extract [17]. Desmodii Styracifolii has been tested by phytochemicals 
where the results are known to contain many elements, such as 
flavonoids, phenolic acids, polysaccharides, and alkaloids. The herb 
Desmodii Styracifolii (Guangjinqiancao), has been used as traditional 
Chinese medicine (TCM), which comes from the Desmodium 
styracifolium (Osb.) Merr. (Leguminosae) dried. The four types of 
flavonoids are schaftoside, isovitexin, luteolin, and apigenin as well 
as one phenolic acid which is ferulic acid in the biological matrix of 
rat plasma and sulfamethoxazole is used as an internal standard (IS) 
[17]. Another natural product, Glycyrrhiza, which is a popular drug 
in China that has been used for years as an anti-cancer, anti-ulcer, 
anti-inflammatory, antiviral, and for improving liver function [19]. ). 
Polyhydroxylated flavonoids which have health effects as anticancer, 
anti-inflammatory, neuroprotective properties. Three 
polymethoxylated flavonoids, kumatakenin, pachypodol, and 
retucine, were isolated from the methanol extract of Melicope 
semecarpifolia. To extract the analytes, a liquid-liquid extraction 
method with ethyl acetate solvent was used and 0.1% formic acid 
was added. Pharmacokinetic measurements of gambogic acid and 
gambogenic acid are also used the liquid-liquid extraction method 
using ethyl acetate with the addition of acidification conditions with 
hydrochloric acid [57, 58]. Precipitation of protein with acetic acid is 
the ratio of acetonitrile-acetate (9: 1, v/v) for pretreatment of 
plasma samples before being analyzed using HPLC. This extraction 
method shows adequate sensitivity, selectivity, and accuracy. 
Determination of catechin, routine, baicalein, quercetin, apigenin-7-
glucoside, and luteolin-7-glucoside in plasma used the method of 
extracting precipitation protein with methanol [73]. Development 
and validation for the quantification of seven flavonoids namely 
pectolinarin, linarin, pectolinarigenin, hispidulin, diosmetin, 
acacetin, and apigenin in rat plasma after oral administration of 
Cirsium japonicum DC. Extracts used a plasma sample preparation 
method by precipitation protein using methanol solvent [76]. The 
solvent that previously added acetic acid [73]. Gallic acid, quercitrin, 
and quercetin, which is a group of phenolic acids and flavonoids, 
were analyzed with the performance of ultra-liquid 
chromatography-ionization electrospray-tandem mass spectrometry 
(UPLC-ESI-MS/MS) extracted in biological samples by precipitation 
protein methods using plasma solvents using solvents methanol and 
1% formic acid added as much as 50 ul [16]. The precipitation 
protein method was initially used in this flavonoid study, there was 
ion suppression and a lower recovery (<50%) was obtained when 
the plasma concentrations exceeded 1000 ng/ml. From the 
discussion of several studies of flavonoids also reported that the use 
of acetonitrile solvents provides a good peak shape for all analytes of 
flavonoids compounds analyzed from plasma samples. Separation is 
shorter [89]. Mangiferin is also a weak organic acid so that a 
hydrochloric acid solution is added at the beginning to maximize the 
conversion of mangiferin into its union form. Besides this mangiferin 
has a tricyclic aromatic ring. Such compounds have poor solubility in 
most non-polar solvents. For testing five types of flavonoids used 
different cellular phase conditions to obtain the best analysis results. 
The acetone solution gives the highest recovery results compared to 
using methanol, acetonitrile, ethanol, diethyl ether, and ethyl acetate 
[73]. The addition of acetic acid at the beginning of the preparation 
by extraction of a precipitation protein method is also one of the 
things that causes the best recovery results compared to using 
hydrochloric acid. The addition of acid to the precipitation protein 
method aims to improve extraction efficiency. Types of acids that 
can be used are 1% acetic acid, 1% formic acid, 0.1% hydrochloric 
acid; 0.2; 0.4 mol/l. Addition of formic acid 1% 50 µl to 100 µl into 
the plasma obtained high analytic recovery results [16]. 
Simultaneous determination of seven flavonoid compounds, i.e. 
routine, vitexin-4 "-O-glucoside, vitexin-2"-O-rhamnoside, 
hyperoside, vitexin, shanyenoside A, and quercetin in rat plasma 
after administration of hawthorn flavonoid (HLF) leaves using IV 
lisionotin as an internal standard (IS). This target compound was 
extracted by precipitation protein method using a methanol solvent 
[89]. 
The development of quantitative methods to measure the 
constituents of herbal samples in biological samples needs to be 
done to obtain information and a better understanding of the 
pharmacological and clinical effects of a product of natural 
ingredients (herbs). This herbal remedy is used as a treatment for 
kidney stones. The extraction sample preparation used was the 
protein deposition method [17, 19]. A methanol solvent was used to 
extract four flavonoids and phenolic acids from the extract of Herba 
Desmodii Styracifolii in plasma. For liquid-liquid extraction and 
precipitation, protein methods are performed to compare which 
method produces good and high recovery results. In this research 
for flavonoid measurement, the liquid-liquid extraction method 
produces a low recovery value. Ethyl acetate, chloroform, diethyl 
ether, or n-butanol solvents were optimized as extract solvents in 
the liquid-liquid extraction method. For the use of the precipitation 
protein method it produces a better recovery value, can eliminate 
plasma protein, the resulting supernatant is cleaner, and results in a 
good separation between peaks without any disturbance. This 
effective result was found when using methanol in the precipitation 
protein method. As explained in the previous discussion that the 
addition of acid into biological samples before the precipitation 
protein process can produce a much higher analyte response value. 
This is because the results of the research show that acidification 
can suppress protein adsorption and promote the release of analyte 
constituents from proteins [17]. 
In addition to precipitation protein methods and liquid-liquid 
extraction, many studies to measure natural compounds in 
biological matrix use the Solid Phase Extraction method. One of 
them is in the pharmacokinetic determination of five types of 
alkaloids (nunciferine, O-nornuciferin, liriodenine, armepavine, and 
pronuciferine) in Lotus Leaf Extract [62] samples of 100 μl and 
standard internal solutions at vortex were then extracted using SPE 
columns (Cleanert PEP-2, 40–60 μm, 60 Å, 10 mg /1 ml; 
Phenomenex, Torrance, CA, USA). In the first stage, the SPE column 
is poured with 50% methanol solution in water and 0.1% formic 
acid. The second stage is used methanol to wash the column. The 
third step was carried out elution with acetonitrile solution after 
adding a plasma sample. The last step of the eluent is centrifuged 
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and the solution obtained is injected or continued to the analysis 
stage [62] n the SPE method, the selection of sorbents is one of the 
key factors of extraction ability because physicochemical properties 
affect the absorption capacity for different types of sorbents. The 
SPE method is used to extract anthocyanin in plasma to measure 
bioavailability. Anthocyanin shows great potential as a natural food 
antioxidant. Four anthocyanins are known in elderberry two main 
components (cyanidin-3-Oglucoside and cyanidin 3-O-
sambubioside). For protein removal, in this study (LiChrospher 
ADS) with a hydrophilic surface (diol silica) and the hydrophobic 
inner surface of the pores (C18) was used [24].  
Research methods for the analysis of Tannic Acid and its metabolites 
in biological samples: Application for Tannic Acid Metabolism in 
mouse also uses the ECC method to prepare samples. The procedure 
is done for 0.5 ml serum or 2 ml urine added 2 ml buffer acetate 0.1 
M (pH 5.0), 0.1 ml 4% ascorbic acid solution (in air), 0.1 ml 4% 
solution Na2EDTA solution (in water), and 0.2 ml of a solution of 
CaCl2 0.6 M (in water) [97]. In this procedure hydrochloric acid was 
used as a solution of that acid with 0.5 ml HCl 1 N. The metabolite 
was extracted three times with a 5 ml ethyl acetate extraction 
solvent after obtaining PA (39.33 mmol) as an internal standard (IS). 
After evaporation to dryness, the residue is dissolved into 2 ml of 
methanol to use the HPLC method [97]. The clinical effects of tannin 
recently have antimutagenic, cardiovascular, anticancer [17, 97, 
102], antioxidant, anti-bacterial [102], cholesterol and serum 
triglyceride levels, and lipogenesis by insulin. Chemically reactive 
tannins and forming inter-and intra-molecular hydrogen bonds that 
facilitate can precipitate macromolecules, such as proteins and 
carbohydrates. For the preparation of penta-O-galloyl--d-glucose 
samples from tannic acid in the plasma matrix for pharmacokinetic 
testing the liquid-liquid extraction technique and the incorporation 
of quantification with reverse-phase HPLC [100]. Gallotannin penta-
O-galloyl-beta-d-glucose (PGG) 
Other herbal compounds are terpene lactone. Terpene lactone is a 
class of bioactive constituents of standard preparations of Ginkgo 
biloba leaf extract, which is widely used as adjunctive therapy in 
patients with ischemic cardiovascular and cerebrovascular diseases. 
In a study conducted by this investigation evaluated human 
pharmacokinetics of lactone terpene ginkgo and the effects of 
carboxylation in the blood [100]. Ginkgo biloba leaf extract is often 
used as an herbal medicinal product as a food supplement and 
cardiovascular treatment [101]. Previous studies of potential 
terpene pharmacological therapeutic agents showed as antioxidant, 
anti-inflammatory, anticancer, analgesic, immune modulation, and 
wound healing [103]. Analysis of lactone terpenes in biological 
matrices was analyzed using a mass spectrometer. Preparation of 
biological samples is used liquid-liquid extraction method with the 
addition of hydrochloric acid before extraction using ethyl acetate 
solvent. The extraction product is then dried by nitrogen gas flow 
and the residual results obtained are dissolved in acetonitrile for 
analysis by mass spectra [100]. Another study reported on the study 
of pharmacokinetic evaluations of the main compounds in the 
dosage formulation of Ginkgo Biloba leaves. Effective compounds 
evaluated include kaempferol, quercetin, isorhamnetin, ginkgolides 
A, ginkgolides B, ginkgolides C and bilobalide. This compound was 
detected by using ultra-performance tandem liquid-chromatography 
mass-spectrometry (UPLC-TMS), which was validated [101]. All 
prepared plasma samples were extracted using liquid-liquid 
extraction techniques. In this extraction process, hydrochloric acid 
was added to the plasma sample to convert the flavonoid glycosides 
into the form of aglycone. In other studies also reported preparation 
techniques for terpene bioavailability of protein precipitation 
techniques with acetonitrile [103]. 
has many biological activities as an 
anti-cancer. The procedure used is plasma and internal standards 
mixed with 20% ascorbic acid, which functions as an antioxidant. 
Then 2% acetic acid solution is added to acidify the sample. Samples 
with acetyl as extraction solution [100]. 
Gallic acid (GA) is an endogenous product found in plants, in free or 
bound form; gallic acid is found in large quantities in tea leaves, 
which are extracted in hot water. Gallic acid is a powerful 
antioxidant that has antimutagenic effects and anti-cancer activity. 
Bioavailability studies were carried out on gallic acid in the plasma 
of test animals such as mice and rabbits. The sample extraction 
method used is the liquid-liquid extraction method. The separated 
plasma sample was centrifuged at 1800 g for 10 min after which 
extraction was carried out with ethyl acetate solvent and the 
separation of the organic fraction [104]. 
The application of biological sample extraction techniques is also 
often used in pharmacokinetic tests for xanthone group compounds. 
One of them is evaluating mangosteen compounds in biological 
samples, as a study Pharmacokinetic characterization of mangosteen 
(Garcinia mangostana) fruit extract standardized to α-mangosteen 
in C57BL/6 mice. For this study, we evaluated the PK profile of α-
mangosteen using a standardized mangosteen extract in C57BL/6 
mice. Mangosteen has antioxidant activity both in vitro. The sample 
preparation used is the protein precipitation technique with the 
addition of acetonitrile [105]. Consumption of mangosteen products 
is currently increasing as a food supplement because it has high 
antioxidant properties [106]. So research to evaluate 
pharmacokinetic studies of mangosteen has been carried out. In 
other studies, methanol is used as a solution for extraction with 
protein precipitation techniques. LC-MS/MS is used to measure the 
quantification. For some antioxidants, it is reported that the 
extraction technique that can be done is the solid phase extraction 
technique in plasma samples [107]. Active compounds that have 
efficacy as other antioxidants include methyl gallate (MG) and Penta 
alloys glucopyranose (PGG). It is a phenolic bioactive compound that 
has the potential as an antioxidant, anti-inflammatory, anti-cancer, 
anti-bacterial, and anti-viral [108]. This study developed an ultra-
performance liquid chromatography-tandem mass spectrometric 
(UPLC-MS/MS) method to simultaneously measure MG and PGG in 
rat blood samples. The biological sample preparation technique 
used is liquid-liquid extraction using ethyl acetate. Before adding the 
ethyl acetate plasma sample mixed with 1% formic acid solution (10 
μl) to acidify the sample, which is then vortexed. 
Bioanalysis sample quantification techniques 
Bioanalytic methods are commonly used for qualitative and 
quantitative analysis of drug substances, drug products, and 
biological samples such as plasma, serum, urine, saliva. Bioanalytic 
methods play an important role in pharmacokinetic studies, 
evaluation, and interpretation of bioavailability and bioequivalence 
data. Furthermore, the method needs to be validated to ensure that 
the method used is accurate, specific, and can be done repeatedly. 
Current technology in the field of drug development, liquid 
chromatography-mass spectrometry (LC-MS) techniques are used as 
bioanalytic techniques that utilize liquid chromatography with mass 
spectrometry. Liquid chromatography-mass spectrometry (LC-
MS/MS) is a technique that uses liquid chromatography (or HPLC) 
with mass spectrometry. LC-MS/MS is commonly used in 
laboratories for qualitative and quantitative analysis of drug 
substances, drug products, and biological samples. This technique is 
usually used to identify, qualitative and quantitative analysis of 
various dosage forms of pharmaceutical products or compounds in 
biological samples including natural pharmaceutical products, due 
to their high sensitivity to the identification of compounds in 
biological complex samples [31]. Chromatographic techniques are 
usually chosen for pharmacokinetic studies of a drug or to look at 
the bioavailability and bioequivalence of a drug compound. 
LC-MS can be used to analyze pharmacokinetic parameters testing 
for several compounds (table 1). The development and validation of 
bioanalytic methods are very important to determine the 
pharmacokinetic parameters and the toxicokinetic profile of drug 
substances. This technique has been widely used for the study of 
bioavailability and bioequivalence. This method uses a set of 
instruments that are more sophisticated and complex when 
compared to other methods that are often used for the analysis of 
drugs in biological fluids. In vivo testing in plasma using test animals. 
In the research process, it will be observed whether in the analysis 
process a drug compound is not disturbed either by the metabolites 
of the compound itself or other endogenous components contained 
in plasma (table 1). 
Validation of bioanalytic methods involves specific laboratory 
documentation and validation process tested and verified for 
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quantitative measurements of a drug substance in the biological 
matrix. Basic validation parameters consist of determinations for 
data quality such as selectivity, sensitivity, model calibration, 
accuracy, precision, stability, quantification limit (LOQ), recovery, 
linearity, the limit of detection, reproducibility, and roughness.  
In analyzing drug concentrations in plasma, high-performance liquid 
chromatography (HPLC) methods are generally used because they 
can separate substances that can interfere with analysis and can 
detect and determine drug levels in plasma that are very small. 
Currently, reverse-phase partition chromatography with column 
C18 is a method commonly used for the analysis of drugs in plasma, 
because it is simpler, selective, and shorter analysis time. Several 
liquid chromatography methods with mass spectrometry [1, 18, 19], 
UV-Vis [22], and fluorescence, DLC HPLC [37], Sensitive analysis of 
aconitine, hypaconitine, mesaconitine and jesaconitine in human 
body fluids and Aconitum tubers by LC/ESI-TOF-MS also be used for 
the analysis of several drug compounds in plasma. The use of liquid 
chromatography with mass spectrometry requires sophisticated 
equipment, high accuracy, and expensive materials, while liquid 
chromatography with UV-Vis spectrophotometer is less sensitive 
and selective for analyzing drugs in small concentrations. Therefore, 
high-performance liquid chromatography with a more sensitive and 
selective fluorescence spectrophotometer is used in several studies 
depending on the physicochemical properties of each drug. The 
principle of pharmacokinetics is the study of changes in drug 
concentration with time. The application of pharmacokinetics in 
optimizing drug therapy and evaluating bioavailability is made 
possible by the skills of analytical chemists who pioneered the 
development of HPLC (Waters). 
Validation method for bioanalysis 
Validation of the bioanalysis method is important so that the 
bioanalysis method used produces accurate results. Validation is the 
process used to establish that quantitative analysis methods are 
suitable for bioanalysis applications. Bioanalysis techniques will 
continue to experience changes by developments and will continue to 
increase with the development of current technology. The bioanalysis 
technique also has its characteristics for each analyte, and specific 
validation needs to be developed for each analyte [104, 109]. 
The importance of validating the bioanalysis method is that it plays 
an important role in showing validation results that are reliable, 
accurate, and trustworthy to support the registration of new or 
reformulated drugs from existing ones. The validation of the 
bioanalysis method refers to agreed-upon Food and Drug 
Administration [110] or The European Medicines Agency (EMEA) 
guidelines. In pharmacokinetic test studies, the method of analyzing 
drug levels in biological samples is the main key to the validity of 
data. Validation of bioanalysis methods is very important to ensure 
the creation, processing of quality data during drug discovery and 
development.  
The US Food and Drug Administration (FDA) guidelines for this 
industry provide general recommendations for validation of 
bioanalytic methods because the validation parameters of the 
bioanalytic methods in this guide are quite complete and suitable for 
determining the validation of analytical methods. This method 
contains a calibration curve, accurate, precision, the lower limit of 
quantification (LLOQ), matrix effects, recovery, and bound.  
Calibration curve 
The calibration curve is the ability of the method to obtain test 
results that are proportional to the concentration in the range of 
expected concentration, while the range is a result of the highest and 
lowest analyte content which shows acceptable accuracy, precision, 
and good linearity [80]. The instrument response to the analyte 
concentration must be known and must be evaluated by 
determining the concentration range. According to the ICH 
definition, the linearity of analytic procedures is its ability (within a 
given range) to obtain test results that are directly proportional to 
the concentration (number) of analyte in the sample. If the total 
range cannot be explained by a single calibration curve, two 
calibration ranges can be validated. The correlation coefficient is 
most used to test linearity. Although the correlation coefficient is 
useful for showing a high level of relationship between 
concentration and response data, it is of little value in making 
linearity [111]. 
In its application, the making of a calibration curve is done by 
diluting the parent standard to various concentrations. This method 
can also be done by spiking with internal standards. Usually, 5-6 
concentration points are used. The results can be calculated from 
the standard peak and internal area ratio values. A good calibration 
curve value is the correlation coefficient must be more than 0.995. 
Accuracy and precision 
Accuracy test is an analytical method that illustrates the closeness of 
the average test results obtained by the method with the actual 
value of the analyte The two most common methods used to 
determine the accuracy or bias of analytic methods are (i) analyzing 
control samples spiked with the analyte and (ii) by comparing 
analytic methods with reference methods. Accuracy is determined 
by the analysis of the sample containing the number of the analyte 
that is known and replicated. The most commonly used method for 
determining accuracy is recovery studies. 
While the precision test is the accuracy of analytic methods that 
describe the closeness of the value of individual analytes that are 
repeated. Precision is expressed as a relative standard deviation 
(coefficient of variation,% KV). Precision testing is done by using 
four levels of concentration (LLOQ, QCL, QCM, and QCH). This 
precision is the proximity of the individual steps of the analyte when 
the procedure is repeatedly applied to several aliquots of a 
homogeneous volume of biological matrix. 
There are various parts for precision, such as repetition, 
intermediate precision, and reproducibility (roughness). Repetition 
or repeatability describes the precision in the same working 
conditions that is carried out by analysts in the same laboratory and 
equipment. Intermediate precision is precision in different 
laboratory conditions, done by different analysts, done on different 
days, and using different equipment at the same time. Whereas 
reproducibility is the accuracy between various laboratories and 
determined by the transfer method. 
Accurate and precise measurements are obtained by replication for 
each concentration six times per day (intra-day) and more than six 
consecutive (inter-day), at least three times within the expected 
concentration range [112]. 
Matrix effects and recovery  
The extraction of this parameter can be calculated by comparing the 
response of the analyte after sample preparation with the response 
of the solution containing the analyte at the maximum theoretical 
concentration. Therefore, the absolute acquisition value cannot 
usually be determined if the sample inspection includes the 
derivatization step, because the derivative is usually not available as 
reference material.  
The matrix and recovery effects were analyzed at three 
concentrations (low, medium, and high) on the standard and sample 
and internal standards. Liquid biological blanks are processed by 
liquid-liquid extraction or other extraction methods depending on 
the type and nature of the analyte to be analyzed. After that, it is 
mixed with a standard solution. After the supernatant is produced 
the remaining solvent is evaporated and dissolved with the 
appropriate solvent.  
Specificity/selectivity 
Selectivity is the ability of analytical methods that only measure 
certain substances carefully and thoroughly to distinguish analyte 
and internal standards with other components such as endogenous 
compounds such as proteins, amino acids, fatty acids, and others 
present in biological fluid samples such as plasma and serum. The 
measurement of selectivity is carried out by measuring six blanks 
with different sources by looking at interference in LLOQ. An 
analytical method is said to be specific if it produces a single 
response to one analyte. In the selectivity analysis, it is also 
necessary to analyze the extent of the disturbance caused by drug 
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metabolites, the disruption of the degradation product formed 
during sample preparation, and the disruption of the possibility of 
the drug being given simultaneously. 
Detection limits and quantization limits 
The limit of detection (LOD) is the smallest analyte concentration test 
parameter in a sample that can be detected on an instrument without 
having to meet accuracy and precision criteria. The detection limit is 
the smallest concentration value of the analyte in the sample which 
still shows the absorption at the instrument. And also for LLOQ is the 
smallest concentration of analytes in the sample but is determined 
quantitatively that meets the criteria of accuracy and precision. 
Range 
The range is the interval between the highest and lowest analyte 
content in a given sample and shows acceptable values of accuracy, 
precision, and linearity.  
Recovery 
The extraction of this parameter can be calculated by comparing the 
response of the analyte after sample preparation with the response 
of the solution containing the analyte at the maximum theoretical 
concentration. Therefore, absolute recovery cannot usually be 
determined if the sample inspection includes the derivatization step, 
because the derivative is usually not available as reference material. 
Stability 
Stability evaluations are carried out to ensure that each step was 
taken during sample preparation and sample analysis, as well as the 
storage conditions of the samples used, do not affect the 
concentration of the analyte. Stability is carried out to ensure each 
step in the analytical method, ensuring the conditions applied to the 
stability test, such as the sample matrix, anticoagulants, materials 
and containers, storage, and analytical conditions are the same as 
those used for the actual research sample. The purpose of the 
stability test is to detect any degradation of the analyte analyzed 
during the process of sample collection, processing, storage, 
preparation, and analysis. All stability can be done during the 
method validation process except for long-term stability.  
There are 3 types of stability tests, namely standard solution 
stability, freeze-thaw stability, short-term stability, and long-term 
stability. 
a. Stability of Freeze  
Thaw Freeze thaw stability is carried out by the way the sample is 
stored and frozen in the freezer at the desired temperature, then 
thawed at room temperature or the temperature at which the 
sample is frozen again by applying the same conditions. In each 
cycle, the sample must be frozen for±12 h before thawing. The 
number of cycles in freeze-thaw stability must equal or exceed the 
study sample cycle. This stability test compares the response of the 
analyte 34 after being stored to the response of the analyte after it 
has been thawed and frozen for 3 cycles to the response of the 
analyte in a fresh sample solution. 
b. Long-term stability  
Long-term stability is tested by the way the sample is stored in the 
freezer under the same storage conditions and has the same 
duration as the study sample. For small molecules that are 
considered to be able to apply the bracketing approach ie case 
stability has been proven for example at-700 and-200 C. For large 
molecules such as peptide and protein stability must be studied at 
each temperature where the research sample will be stored. This 
stability test compares the response of the analyte after being stored 
at the time of analysis to the response of the analyte after storage of 
the response of the analyte in a sample solution that is still new. 
c. Short-term stability  
Samples are stored at room temperature or the temperature at 
which they will be processed. The length of the test is adjusted to the 
length of the sample at room temperature. A minimum of 3 samples 
was used at low and high concentrations in the biological matrix 
stored at room temperature for 24 h. This stability test compares 35 
responses of the analyte after being stored to the response of the 
analyte after storage of the response in a sample solution that is still 
new. 
d. Stability of standard solutions  
The stability of analytes and internal standards is assessed using a 
minimum of 6 h at room temperature and 30 d in cold temperatures. 
This stability test compares the response of the analyte after being 
stored in the response of the analyte in a fresh stock solution [39]. 
CONCLUSION 
Bioanalysis part of important role in therapeutic evaluation studies, 
interpretation of bioavailability and bioequivalence studies, 
pharmacokinetic studies, pharmacodynamics. The development of 
natural medicinal products according to those stipulated by the 
health department must be scientifically justified. Selective and 
sensitive bioanalysis methods for quantitative assessment of a drug 
and its metabolites are essential for successful pre-clinical and 
clinical pharmacological testing. The selection of extraction methods 
with suitable solvents and the selection of methods for separating 
drug components from effective biological endogens is very 
important. Some separation of drugs from plasma are (1) Protein 
Precipitation (PPT) (2) Liquid-liquid extraction (LLE) (3) Solid-
phase extraction (SPE). The measurement of analytes from the 
biological matrix must be validated. Validation of the bioanalysis 
method includes all procedures which show that the specific method 
used for quantitative measurement of analytes originating in the 
biological matrix, such as blood, plasma, serum, or urine, can be 
trusted and can be repeated repeatedly for the intended use. The 
basic parameters of validation aim to determine quality which 
includes criteria such as selectivity, sensitivity, linearity, accuracy, 
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